Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.

Also called NCT06393348

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Phase 2
Enrolled
  • 155 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06393348
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06393348. Randomized; double masking; primary purpose other. Start 2024-05-17 (actual); primary completion 2024-11-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
Intervention (Drug)
HRS-7535
Intervention (Drug)
Placebo
Lead sponsor
Shandong Suncadia Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06393348
Content hash
9ccb3184de4d694574df2a790ea90d16d425c5b54fc339cab2d6232a288b0038